These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22798404)

  • 1. Public health. Getting HIV treatment to the most people.
    Lynch S; Ford N; van Cutsem G; Bygrave H; Janssens B; Decroo T; Andrieux-Meyer I; Roberts T; Balkan S; Casas E; Ferreyra C; Bemelmans M; Cohn J; Kahn P; Goemaere E
    Science; 2012 Jul; 337(6092):298-300. PubMed ID: 22798404
    [No Abstract]   [Full Text] [Related]  

  • 2. Demedicalizing AIDS prevention and treatment in Africa.
    Ellman T
    N Engl J Med; 2015 Jan; 372(4):303-5. PubMed ID: 25607425
    [No Abstract]   [Full Text] [Related]  

  • 3. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa.
    Igumbor JO; Scheepers E; Ebrahim R; Jason A; Grimwood A
    AIDS Care; 2011 Feb; 23(2):231-6. PubMed ID: 21259136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a case management program for HIV clients in Rwanda.
    Thurman TR; Haas LJ; Dushimimana A; Lavin B; Mock N
    AIDS Care; 2010 Jun; 22(6):759-65. PubMed ID: 20461574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
    Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
    AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility.
    Wilson DP; Blower SM
    PLoS Med; 2006 Mar; 3(3):e160. PubMed ID: 16563042
    [No Abstract]   [Full Text] [Related]  

  • 8. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The introduction of antiretroviral therapy in Malawi].
    Zijlstra EE; van Oosterhout JJ
    Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India.
    Safren SA; Kumarasamy N; Hosseinipour M; Harwood MM; Hoffman I; McCauley M; Jumbe A; Nyirenda C; Mimiaga MJ; Solomon S; Celentano D; Mayer KH
    AIDS Behav; 2006 Jul; 10(4):443-50. PubMed ID: 16604297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
    Kamoto K; Aberle-Grasse J;
    Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of adherence to antiretroviral treatment and therapeutic success among children in South Africa.
    Muller AD; Bode S; Myer L; Stahl J; von Steinbuchel N
    AIDS Care; 2011 Feb; 23(2):129-38. PubMed ID: 20645192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare worker crisis in Africa jeopardises the fight against HIV/AIDS.
    Ryan M; Tchum I; Coakley P; Merry C
    Ir Med J; 2005 Feb; 98(2):61. PubMed ID: 15835516
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors of antiretroviral (ARV) drug adherence among people living with HIV/AIDS attending at Taksin Hospital, Bangkok, Thailand.
    Chamroonsawasdi K; Insri N; Pitikultang S
    J Med Assoc Thai; 2011 Jul; 94(7):775-81. PubMed ID: 21774282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early warning indicators for HIV drug resistance in Malawi.
    Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
    Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.